Avatar
Listsand89

0 Following 0 Followers
1
IcsResultsAssociations of DC-SCRIPT with clinicopathological factors and histological and intrinsic breast cancer subtypesThe relationship between DC-SCRIPT and patient and tumor characteristics was investigated with the use of non-parametric methods (Spearman rank correlations for continuous variables and Wilcoxon rank-sum for dichotomized or Kruskal-Wallis test for ordered variables). To reduce
1
IcsResultsAssociations of DC-SCRIPT with clinicopathological factors and histological and intrinsic breast cancer subtypesThe relationship between DC-SCRIPT and patient and tumor characteristics was investigated with the use of non-parametric methods (Spearman rank correlations for continuous variables and Wilcoxon rank-sum for dichotomized or Kruskal-Wallis test for ordered variables). To reduce
1
Ship between DC-SCRIPT mRNA levels measured in primary breast cancers and tumor aggressiveness in a much larger, independent, breast cancer cohort. The main clinical endpoints for assessing the prognostic value of DC-SCRIPT expression were disease-free survival (DFS), metastasis-free survival (MFS), and overall survival (OS) in lymph node-negative (LNN) patients who had not received adjuvant syste
1
Ship between DC-SCRIPT mRNA levels measured in primary breast cancers and tumor aggressiveness in a much larger, independent, breast cancer cohort. The main clinical endpoints for assessing the prognostic value of DC-SCRIPT expression were disease-free survival (DFS), metastasis-free survival (MFS), and overall survival (OS) in lymph node-negative (LNN) patients who had not received adjuvant syste
1
Ship between DC-SCRIPT mRNA levels measured in primary breast cancers and tumor aggressiveness in a much larger, independent, breast cancer cohort. The main clinical endpoints for assessing the prognostic value of DC-SCRIPT expression were disease-free survival (DFS), metastasis-free survival (MFS), and overall survival (OS) in lymph node-negative (LNN) patients who had not received adjuvant syste
1
D in these concentrations of E-64 for nearly 6 days. Share of morula, and blastocyst shaped have been identified on day seven? in 4 replicates.ExperimentFollowing resolve of optimum focus of E64, expanded blastocysts acquired from in vitro culture of embryos while in the presence (IVC+) or absence (IVC-) of 1 M of E-64 ended up vitrified and warmed. Vitrified/ warmed blastocysts, right here called
1
D in these concentrations of E-64 for nearly 6 days. Share of morula, and blastocyst shaped have been identified on day seven? in 4 replicates.ExperimentFollowing resolve of optimum focus of E64, expanded blastocysts acquired from in vitro culture of embryos while in the presence (IVC+) or absence (IVC-) of 1 M of E-64 ended up vitrified and warmed. Vitrified/ warmed blastocysts, right here called
1
D in these concentrations of E-64 for nearly 6 days. Share of morula, and blastocyst shaped have been identified on day seven? in 4 replicates.ExperimentFollowing resolve of optimum focus of E64, expanded blastocysts acquired from in vitro culture of embryos while in the presence (IVC+) or absence (IVC-) of 1 M of E-64 ended up vitrified and warmed. Vitrified/ warmed blastocysts, right here called
1
Some scientists have revealed which the presence of lifeless cells can be a common physiological finding in mammalian pre-implantation progress as well as quantity of lifeless cells is elevated by vitrification [6]. Mobile demise in embryos has actually been generally affiliated with programmed cell demise or apoptosis [7] which is considered as likely mobile reaction to suboptimal developmental a
1
Some scientists have revealed which the presence of lifeless cells can be a common physiological finding in mammalian pre-implantation progress as well as quantity of lifeless cells is elevated by vitrification [6]. Mobile demise in embryos has actually been generally affiliated with programmed cell demise or apoptosis [7] which is considered as likely mobile reaction to suboptimal developmental a